| Soil nitrate reducing processes–drivers, mechanisms for spatial variation, and significance for nitrous oxide production M Giles, N Morley, EM Baggs, TJ Daniell Frontiers in microbiology 3, 407, 2012 | 276 | 2012 |
| Carbon and oxygen controls on N2O and N2 production during nitrate reduction N Morley, EM Baggs Soil Biology and Biochemistry 42 (10), 1864-1871, 2010 | 274 | 2010 |
| Production of NO, N2O and N2 by extracted soil bacteria, regulation by NO2− and O2 concentrations N Morley, EM Baggs, P Dörsch, L Bakken FEMS Microbiology Ecology 65 (1), 102-112, 2008 | 206 | 2008 |
| Rhizosphere priming can promote mobilisation of N-rich compounds from soil organic matter CJ Murphy, EM Baggs, N Morley, DP Wall, E Paterson Soil Biology and Biochemistry 81, 236-243, 2015 | 145 | 2015 |
| Biphasic behavior of anammox regulated by nitrite and nitrate in an estuarine sediment M Trimmer, JC Nicholls, N Morley, CA Davies, J Aldridge Applied and Environmental Microbiology 71 (4), 1923-1930, 2005 | 138 | 2005 |
| CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial M Gleeson, C Peckitt, YM To, L Edwards, J Oates, A Wotherspoon, ... The Lancet Haematology 5 (5), e190-e200, 2018 | 72 | 2018 |
| Barley genotype influences stabilization of rhizodeposition-derived C and soil organic matter mineralization L Mwafulirwa, EM Baggs, J Russell, T George, N Morley, A Sim, ... Soil Biology and Biochemistry 95, 60-69, 2016 | 71 | 2016 |
| Nitrogen availability alters rhizosphere processes mediating soil organic matter mineralisation CJ Murphy, EM Baggs, N Morley, DP Wall, E Paterson Plant and Soil 417, 499-510, 2017 | 61 | 2017 |
| Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma L Coyle, NJ Morley, A Rambaldi, KD Mason, G Verhoef, CL Furness, ... Leukemia & lymphoma 61 (9), 2103-2112, 2020 | 58 | 2020 |
| Substrate Induced Denitrification over or under Estimates Shifts in Soil N2/N2O Ratios NJ Morley, DJ Richardson, EM Baggs PLoS One 9 (9), e108144, 2014 | 47 | 2014 |
| Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a … P Hillmen, A Pitchford, A Bloor, A Broom, M Young, B Kennedy, ... The Lancet Oncology 24 (5), 535-552, 2023 | 40 | 2023 |
| Methane and nitrous oxide fluxes across an elevation gradient in the tropical Peruvian Andes YA Teh, T Diem, S Jones, LP Huaraca Quispe, E Baggs, N Morley, ... Biogeosciences 11 (8), 2325-2339, 2014 | 39 | 2014 |
| Ibrutinib plus rituximab is superior to FCR in previously untreated CLL: results of the phase III NCRI FLAIR trial P Hillmen, A Pitchford, A Bloor, A Broom, M Young, B Kennedy, ... Blood 138, 642, 2021 | 37 | 2021 |
| Combined effects of rhizodeposit C and crop residues on SOM priming, residue mineralization and N supply in soil LD Mwafulirwa, EM Baggs, J Russell, N Morley, A Sim, E Paterson Soil Biology and Biochemistry 113, 35-44, 2017 | 34 | 2017 |
| Open-label, phase 2 study of blinatumomab after first-line rituximab-chemotherapy in adults with newly diagnosed, high-risk diffuse large B-cell lymphoma DA Katz, MP Chu, KA David, C Thieblemont, NJ Morley, SS Khan, Y Chen, ... Blood 134, 4077, 2019 | 24 | 2019 |
| In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission … DI Marks, L Clifton-Hadley, M Copland, J Hussain, TF Menne, A McMillan, ... The Lancet Haematology 9 (4), e276-e288, 2022 | 20 | 2022 |
| Efficacy and safety of parsaclisib in patients with relapsed or refractory follicular lymphoma: primary analysis from a phase 2 study (CITADEL-203) RC Lynch, A Avigdor, MS McKinney, S Paneesha, B Wahlin, JS Hrom, ... Blood 138, 813, 2021 | 13 | 2021 |
| Sudden or cardiac deaths on ibrutinib-based therapy were associated with a prior history of hypertension or cardiac disease and the use of ACE-inhibitors at study entry … T Munir, A Pitchford, A Bloor, A Broom, M Young, B Kennedy, R Walewska, ... Blood 138, 2636, 2021 | 13 | 2021 |
| Transformed follicular lymphoma: the 25-year experience of a UK provincial lymphoma treatment centre NJ Morley, LS Evans, J Goepel, BW Hancock Oncology reports 20 (4), 953-956, 2008 | 13 | 2008 |
| Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma A Viardot, G Hess, RC Bargou, NJ Morley, G Gritti, ME Goebeler, ... Leukemia & Lymphoma 61 (11), 2767-2770, 2020 | 12 | 2020 |
